[Recombinant α-2 interferon in preventing the progression of melanoma].
A brief history of interferon application in the treatment of cutaneous melanoma is represented.
S I
SI
Korovin
M N
MN
Kukushkina
A Iu
AIu
Palivets
F V
FV
Fil'chakov
E S
ES
Shumilina
V V
VV
Ostafĭchuk
D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D018450:Disease Progression; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects / Q000266:history / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy* / Q000266:history / Q000401:mortality / Q000517:prevention & control; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000266:history / Q000627:therapeutic use; D013997:Time Factors
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins